In 2012, an all-time high of 28,000 principal investigators participated in FDA regulated research, according to a study in the March/April Tufts Center for the Study of Drug Development (CSDD) Impact Report. However, compound annual growth in the number of active...
Join Beth Harper, BS, MBA, President, Clinical Performance Partners, Inc. on January 15th as she presents and discusses the practical applications of the Electronic Medical Records (EMR) systems for patient recruitment, during the SCRS January GCP Webinar. Pearl IRB...
Pearl staff is attending the first INpact lunch meeting of 2013 on Wednesday, January 23rd. INpact is focused on supporting the medical device industry in Indiana. Please attend the lunch to network and learn more about the new bimonthly meeting format. Time: ...
On October 14, the 7th Annual Site Solutions Summit announced the formation of a new association focusing on the needs and challenges of the research site. President of The Society for Clinical Research Sites (SCRS), Christine Pierre is aiming to “provide...
In a recent article, The Association of Clinical Research Organizations (ACRO) has voiced its concern that the Sunshine Act may have negative effects on US drug research. The Sunshine Act requires the reporting of payments made by biopharma to physicians and was...
This event will be a great gathering for clinical research professionals. Gretchen Bowker, Pearl IRB COO is speaking at the event. The title of the event is: Ask the IRB’s- Answers might be different than what your IRB is telling you. Pearl will also be...
